AnaptysBio Logo

AnaptysBio

🇺🇸
ANAB
US0327241065

AnaptysBio is a leading U.S.-based biotechnology company specializing in the development of innovative antibody therapies for inflammatory diseases. Through its proprietary technology platform, AnaptysBio researches and develops targeted biological agents for advanced medical applications.

Next Quarterly Earnings

Tuesday, November 10, 2026
CW 46
After-Hours
In 75 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 13, 2026

Stock Price

Frequently asked questions

When will AnaptysBio report its next quarterly earnings?

AnaptysBio is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did AnaptysBio last report quarterly earnings?

AnaptysBio last reported quarterly earnings on 5/12/2026 (Q1 2026). Earnings per share (EPS) came in at -1.84 USD.

How do I add the AnaptysBio earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$0.11
Actual:
Q1 2026
Missed
Estimate:-$0.74
Actual:-$1.84
Difference:-$1.10
Price reaction (1 day):-4.4 %
Price reaction (7 days):-8.9 %
Q4 2025
Beat
Estimate:$0.57
Actual:$1.05
Difference:+$0.48
Price reaction (1 day):+14.6 %
Price reaction (7 days):+17.4 %

Company Information

Name
AnaptysBio
Ticker Symbol
ANAB
ISIN
US0327241065
Country
🇺🇸
USA
Sector
More Financial Information